deltatrials
Terminated OBSERVATIONAL NCT03092297

Insufficient Cellular Oxygen in ICU Patients With Anaemia (INOX ICU-2)

Insufficient Cellular Oxygen in ICU Patients With Anaemia: the INOX ICU-2 Study

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions Anemia Critical Care Erythrocyte Transfusion Mitochondria Oxygen
Updated 17 times since 2017 Last updated: Jan 17, 2023 Started: May 16, 2017 Primary completion: Jul 1, 2021 Completion: Dec 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

COVID-19 pandemic

Other terminated trials from Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

See all terminations from Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Other Anemia trials with similar outcome

Browse all Anemia trials

Listed as NCT03092297, this observational or N/A phase trial focuses on Anemia and Critical Care and remains terminated or withdrawn. Sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), it has been updated 17 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Apr 2017 – ~Jun 2017 · 2 months · monthly snapshot~Jun 2017 – ~Aug 2017 · 2 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Nov 2019 · 15 months · monthly snapshot~Nov 2019 – ~Jul 2020 · 8 months · monthly snapshot~Jul 2020 – ~Nov 2020 · 4 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Nov 2021 · 7 months · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Feb 2023 · 14 months · monthly snapshot~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated

  3. Feb 2023 — Jul 2024 [monthly]

    Terminated

    Status: Recruiting → Terminated

  4. Dec 2021 — Feb 2023 [monthly]

    Recruiting

  5. Nov 2021 — Dec 2021 [monthly]

    Recruiting

▶ Show 12 earlier versions

  1. Apr 2021 — Nov 2021 [monthly]

    Recruiting

  2. Jan 2021 — Apr 2021 [monthly]

    Recruiting

  3. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  4. Jul 2020 — Nov 2020 [monthly]

    Recruiting

  5. Nov 2019 — Jul 2020 [monthly]

    Recruiting

  6. Aug 2018 — Nov 2019 [monthly]

    Recruiting

  7. Jun 2018 — Aug 2018 [monthly]

    Recruiting

  8. May 2018 — Jun 2018 [monthly]

    Recruiting

  9. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  10. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  11. Jun 2017 — Aug 2017 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  12. Apr 2017 — Jun 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
  • Erasmus Medical Center
  • Leiden University Medical Center
  • Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research
Data source: Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations